4 / 5 Stars
4 4 5 4 3
Zacks Investment Research
Standard & Poor's
U.S. News evaluated 107 Long/Short Equity Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.
The fund has returned 25.46 percent over the past year, and 8.35 percent over the past three years.
|Trailing Returns||Updated 02.28.2014|
|Year to date||6.4%|
|3 Years (Annualized)||8.3%|
|5 Years (Annualized)||N/A|
|10 Years (Annualized)||N/A|
The investment seeks capital appreciation. The fund invests primarily (at least 80% of its net assets) in stocks of companies engaged in the health care sector using a long/short growth strategy in seeking to capture alpha, reduce volatility, and preserve capital in declining markets. Its holdings may generally range from small companies with over $250 million in market capitalization at the time of purchase to larger, established firms in the health care industry. The fund typically holds between 15 and 75 securities long, and between 15 and 75 securities short.
Fees are Above Average compared to funds in the same category.
Turner Medical Sciences Long/Short Fund has an expense ratio of 1.53 percent.
Risk is Below Average compared to funds in the same category according to Morningstar.